Dermata Therapeutics (DRMA) Earnings Date & Reports
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
DRMA is expected to report earnings to rise 13.65% to -54 cents per share on August 18
Q2'26
Est.
$-0.55
Q1'26
Beat
by $1.02
Q4'25
Missed
by $1.02
Q3'25
Missed
by $1.33
Q2'25
Missed
by $1.22
The last earnings report on May 13 showed earnings per share of -47 cents, beating the estimate of -150 cents. With 58.87K shares outstanding, the current market capitalization sits at 4.99M.